GLASF
Price
$6.27
Change
-$0.01 (-0.16%)
Updated
Dec 3 closing price
Capitalization
505.63M
104 days until earnings call
Intraday BUY SELL Signals
TSNDF
Price
$0.59
Change
+$0.06 (+11.32%)
Updated
Dec 3 closing price
Capitalization
177.11M
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLASF vs TSNDF

Header iconGLASF vs TSNDF Comparison
Open Charts GLASF vs TSNDFBanner chart's image
Glass House Brands
Price$6.27
Change-$0.01 (-0.16%)
Volume$118.5K
Capitalization505.63M
TerrAscend
Price$0.59
Change+$0.06 (+11.32%)
Volume$354.83K
Capitalization177.11M
GLASF vs TSNDF Comparison Chart in %
GLASF
Daily Signal:
Gain/Loss:
TSNDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLASF vs. TSNDF commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and TSNDF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (GLASF: $6.27 vs. TSNDF: $0.59)
Brand notoriety: GLASF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 62% vs. TSNDF: 65%
Market capitalization -- GLASF: $505.63M vs. TSNDF: $177.11M
GLASF [@Pharmaceuticals: Generic] is valued at $505.63M. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $177.11M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileTSNDF’s FA Score has 0 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • TSNDF’s FA Score: 0 green, 5 red.
According to our system of comparison, TSNDF is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 6 TA indicator(s) are bullish while TSNDF’s TA Score has 5 bullish TA indicator(s).

  • GLASF’s TA Score: 6 bullish, 4 bearish.
  • TSNDF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLASF is a better buy in the short-term than TSNDF.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а -0.95% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was +32.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.75%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was +19.08%.

Reported Earning Dates

GLASF is expected to report earnings on Mar 18, 2026.

TSNDF is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLASF($506M) has a higher market cap than TSNDF($177M). GLASF has higher P/E ratio than TSNDF: GLASF (513.07) vs TSNDF (14.84). GLASF YTD gains are higher at: 8.103 vs. TSNDF (-8.708). GLASF has higher annual earnings (EBITDA): 49M vs. TSNDF (11.3M). GLASF has more cash in the bank: 40.7M vs. TSNDF (27.7M). GLASF has less debt than TSNDF: GLASF (72.8M) vs TSNDF (242M). TSNDF has higher revenues than GLASF: TSNDF (300M) vs GLASF (222M).
GLASFTSNDFGLASF / TSNDF
Capitalization506M177M286%
EBITDA49M11.3M434%
Gain YTD8.103-8.708-93%
P/E Ratio513.0714.843,458%
Revenue222M300M74%
Total Cash40.7M27.7M147%
Total Debt72.8M242M30%
FUNDAMENTALS RATINGS
GLASF vs TSNDF: Fundamental Ratings
GLASF
TSNDF
OUTLOOK RATING
1..100
656
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
6261
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
1738

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSNDF's Valuation (58) in the null industry is somewhat better than the same rating for GLASF (93). This means that TSNDF’s stock grew somewhat faster than GLASF’s over the last 12 months.

TSNDF's Profit vs Risk Rating (100) in the null industry is in the same range as GLASF (100). This means that TSNDF’s stock grew similarly to GLASF’s over the last 12 months.

GLASF's SMR Rating (93) in the null industry is in the same range as TSNDF (98). This means that GLASF’s stock grew similarly to TSNDF’s over the last 12 months.

TSNDF's Price Growth Rating (61) in the null industry is in the same range as GLASF (62). This means that TSNDF’s stock grew similarly to GLASF’s over the last 12 months.

TSNDF's P/E Growth Rating (96) in the null industry is in the same range as GLASF (100). This means that TSNDF’s stock grew similarly to GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASFTSNDF
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signal:
Gain/Loss:
TSNDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMIYX24.590.23
+0.94%
Lord Abbett Micro Cap Growth I
YACKX25.860.16
+0.62%
AMG Yacktman I
AMOMX25.070.09
+0.36%
AQR Large Cap Momentum Style I
CLTIX17.760.04
+0.23%
Catalyst/Lyons Tactical Allocation I
VKSIX19.640.02
+0.10%
Virtus KAR Small-Mid Cap Core I

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-0.22%
TSNDF - GLASF
63%
Loosely correlated
+11.96%
GTBIF - GLASF
62%
Loosely correlated
+0.78%
TCNNF - GLASF
60%
Loosely correlated
-1.00%
CURLF - GLASF
57%
Loosely correlated
+4.72%
CRLBF - GLASF
57%
Loosely correlated
-2.43%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
+11.96%
GTBIF - TSNDF
78%
Closely correlated
+0.78%
CRLBF - TSNDF
76%
Closely correlated
-2.43%
TCNNF - TSNDF
76%
Closely correlated
-1.00%
CURLF - TSNDF
74%
Closely correlated
+4.72%
JUSHF - TSNDF
72%
Closely correlated
+1.27%
More